The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.
Cedars-Sinai Cancer investigators have identified two new treatment options for men with recurrent prostate cancer—both of which helped patients live longer without their disease progressing than the current standard treatment.
Lali Medina-Kauwe was named the inaugural Carol Moss Foundation Chair in Medical Discovery at Cedars-Sinai. The support of the Carol Moss Foundation, whose endowment was established by the foundation’s late president, Samuel W. Halper, will enable Medina-Kauwe to advance innovative research in nanomedicine.
Niki Patel, a fellowship-trained hematologist-oncologist board certified in internal medicine and medical oncology, was named to the Division of Medical Oncology at Cedars-Sinai Cancer.
Gynecologic oncologist Margaret Liang was named director for the Gynecologic Oncology Fellowship Program at Cedars-Sinai Cancer. She also joined the Division of Gynecologic Oncology, providing care and clinical services for patients within the Department of Obstetrics and Gynecology.
Karine Sargsyan, formerly director of one of the world’s largest clinical biobanks, was named scientific director of Cedars-Sinai Cancer’s OncoBiobank.
The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recognized with official accreditation for CAR T-cell therapy from the Foundation for the Accreditation of Cellular Therapy, an international accrediting body. The program was also ranked among the top adult bone marrow transplant programs in the U.S. for a third year.
Jeannie Shen was appointed medical director of the Breast Program at Huntington Hospital, an affiliate of Cedars-Sinai, and medical director of the International Health Program at Cedars-Sinai Cancer at Huntington Hospital.
Yuan Yuan, a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy, was named director of Breast Oncology at Cedars-Sinai Cancer.
